Network bioinformatics analysis provides insight into drug repurposing for COVID-19

• Main Authors: Xu Li (Author), Jinchao Yu (Author), Zhiming Zhang (Author), Jing Ren (Author), Alex E. Peluffo (Author), Wen Zhang (Author), Yujie Zhao (Author), Jiawei Wu (Author), Kaijing Yan (Author), Daniel Cohen (Author), Wenjia Wang (Author)
• Format: Book
• Published: Elsevier, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The COVID-19 disease caused by the SARS-CoV-2 virus is a health crisis worldwide. While developing novel drugs and vaccines is long, repurposing existing drugs against COVID-19 can yield treatments with known preclinical, pharmacokinetic, pharmacodynamic, and toxicity profiles, which can rapidly ent...